Oscar Health shareholders approve director slate, executive pay, and auditor at annual meeting
Filed June 9, 2026 · Period ending June 4, 2026 · ~1 min read
Key Changes
-
low
All eight director nominees elected to one-year terms through 2027, including CEO Mario Schlosser and Chairman Mark Bertolini, each receiving over 750 million votes in favor with minimal opposition.
Item 5.07 verify on EDGAR → -
low
Executive compensation approved in advisory vote with 98.9% support (765M for vs 8.9M against), signaling strong shareholder backing of management pay practices.
Item 5.07 verify on EDGAR → -
low
PricewaterhouseCoopers ratified as 2026 auditor with 99.9% approval, maintaining continuity in external financial oversight.
Item 5.07 verify on EDGAR →
See the full narrative summary and section-by-section diff — create a free account to read more. Takes 30 seconds.
Partner
Trade OSCR commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 9, 2026 8:37 PM